Twenty-year experience in liver surgery in metastatic colorectal patients: a case series study in Ukraine

被引:1
作者
Burlaka, Anton [1 ,8 ]
Ryzhov, Anton [7 ]
Ostapenko, Yurii [3 ]
Bankovska, Natalia [4 ]
Kopchak, Kostiantyn [5 ]
Zvirych, Vitalii [1 ]
Golovko, Tetiana [2 ]
Shypko, Andriy [6 ]
Lukashenko, Andrii [6 ]
机构
[1] Natl Canc Inst, Dept Colorectal Canc, Kiev, Ukraine
[2] Natl Canc Inst, Dept Radiol, Kiev, Ukraine
[3] Natl Canc Inst, Dept Minimally Invas Surg, Kiev, Ukraine
[4] Natl Canc Inst, Dept Sci, Kiev, Ukraine
[5] Natl Canc Inst, Dept HPB, Kiev, Ukraine
[6] Natl Canc Inst, Kiev, Ukraine
[7] Natl Canc Registry Ukraine, Dept Canc Control, Kiev, Ukraine
[8] Colorectal Canc Dept NCI, UA-03022 Kiev, Ukraine
来源
ANNALS OF MEDICINE AND SURGERY | 2023年 / 85卷 / 05期
关键词
case series; colorectal cancer; liver metastases; liver resection; parenchyma sparing; RESECTION; CANCER; HEPATECTOMY; SURVIVAL; LIGATION; EXCISION;
D O I
10.1097/MS9.0000000000000619
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background:For the last three decades, the world surgical community successfully adopted different surgical strategies for colorectal cancer (CRC) patients with liver metastases (LM), however, we are still seeing the evolution of treatment guidelines. The purpose of the study was to analyze a 20-year evolution of CRC patients with LM being treated in a specialized state Ukrainian oncological center. Materials and methods:The retrospective analysis of 1118 CRC patient cases using prospectively collected patient data from the National Cancer Institute registry. The time ranges between 2000-2010 and 2011-2022 and the LM manifestation - metachronous (M0)/synchronous (M1) were the two main grouping criteria. Results:The overall survival 5-year survival of patients who had surgery between 2000-2011 and 2012-2022 was 51.3 and 58.2% (P=0.61) for the M0 cohort and 22.6 and 34.7% at M1 (P=0.002), respectively. The results of the multivariate analysis in 1118 cases revealed that liver re-resection and regional lymph node dissection >= D2 were associated with better overall survival [hazard ratio (95% CI)=0.76 (0.58-0.99) P=0.04] in the M0 cohort and receiving at least 15 courses of chemotherapy had better recurrence-free survival rates [hazard ratio (95% CI)=0.97 (0.95-0.99), P=0.03] for both M0 and M1. Conclusions:It was shown the improvement of the oncological prognosis for CRC patients with synchronous LM who were treated after 2012. The adaptation of world experience algorithms and the surgical strategy evolution have become the root cause of the above.
引用
收藏
页码:1413 / 1419
页数:7
相关论文
共 50 条
  • [21] Breast-Conserving Surgery Followed by Partial or Whole Breast Irradiation: Twenty-Year Results of a Phase 3 Clinical Study
    Polgar, Csaba
    Major, Tibor
    Takacsi-Nagy, Zoltan
    Fodor, Janos
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (04): : 998 - 1006
  • [22] Surgery in asymptomatic patients with colorectal cancer and unresectable liver metastases: the authors' experience
    Boselli, Carlo
    Renzi, Claudio
    Gemini, Alessandro
    Castellani, Elisa
    Trastulli, Stefano
    Desiderio, Jacopo
    Corsi, Alessia
    Barberini, Francesco
    Cirocchi, Roberto
    Santoro, Alberto
    Parisi, Amilcare
    Redler, Adriano
    Noya, Giuseppe
    ONCOTARGETS AND THERAPY, 2013, 6 : 267 - 272
  • [23] Current use of MRI in patients with liver metastatic colorectal cancer: a population-based study
    Pech, Laurianne
    Cercueil, Jean-Pierre
    Jooste, Valerie
    Krause, Denis
    Facy, Olivier
    Bouvier, Anne-Marie
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 29 (10) : 1126 - 1130
  • [24] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Ljunggren, Malin
    Weibull, Caroline E.
    Rosander, Emma
    Palmer, Gabriella
    Glimelius, Bengt
    Martling, Anna
    Nordenvall, Caroline
    BMC CANCER, 2022, 22 (01)
  • [25] Benefits of simultaneous laparoscopic colorectal surgery and liver resection for colorectal cancer with synchronous liver metastases: Retrospective case-matched study
    Taesombat, Wipusit
    Kanjanasilp, Prapon
    Nonthasoot, Bunthoon
    Sutherasan, Methee
    Vorasittha, Athaya
    Sirichindakul, Boonchoo
    ANNALS OF MEDICINE AND SURGERY, 2020, 58 : 120 - 123
  • [26] Hospital factors and metastatic surgery in colorectal cancer patients, a population-based cohort study
    Ljunggren, Malin
    Weibull, Caroline E.
    Rosander, Emma
    Palmer, Gabriella
    Glimelius, Bengt
    Martling, Anna
    Nordenvall, Caroline
    BMC CANCER, 2022, 22 (01)
  • [27] Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized Study
    Ruers, Theo J. M.
    Wiering, Bastiaan
    van der Sijp, Joost R. M.
    Roumen, Rudi M.
    de Jong, Koert P.
    Comans, Emile F. I.
    Pruim, Jan
    Dekker, Helena M.
    Krabbe, Paul F. M.
    Oyen, Wim J. G.
    JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (07) : 1036 - 1041
  • [28] The preoperative experience of patients undergoing surgery for colorectal cancer: A phenomenological study
    Worster, Barbara
    Holmes, Susan
    EUROPEAN JOURNAL OF ONCOLOGY NURSING, 2008, 12 (05) : 418 - 424
  • [29] Management of isolated nonresectable liver metastases in colorectal cancer patients: a case-control study of isolated hepatic perfusion with melphalan versus systemic chemotherapy
    van Iersel, L. B. J.
    Koopman, M.
    de Velde, C. J. H. van
    Mol, L.
    van Meerten, E. L. van Persijn
    Hartgrink, H. H.
    Kuppen, P. J. K.
    Vahrmeijer, A. L.
    Nortier, J. W. R.
    Tollenaar, R. A. E. M.
    Punt, C.
    Gelderblom, H.
    ANNALS OF ONCOLOGY, 2010, 21 (08) : 1662 - 1667
  • [30] The experience of immune checkpoint inhibitors in Chinese patients with metastatic melanoma: a retrospective case series
    Wen, Xizhi
    Ding, Ya
    Li, Jingjing
    Zhao, Jingjing
    Peng, Ruiqing
    Li, Dandan
    Zhu, Baoyan
    Wang, Yao
    Zhang, Xing
    Zhang, Xiaoshi
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (09) : 1153 - 1162